Transdisciplinary Energetics and Cancer (TREC)


Obesity and cancer?
Why are we meeting in Philadelphia?
These are question not commonly asked on our CNiC blog. Let me explain a little of our new center on obesity and cancer, and link you to our related resources.

NCI convened the first meeting of funded centers working together on issues relating energy balance, obesity, and cancer. My role at this meeting with Sarah Gehlert, leading our TREC at Washington University in St. Louis was to provide an overview of our Center and the projects we have embarked upon to address obesity and cancer, with a particular focus on translating our findings to the burden of cancer in Missouri. See our web site. 

Our 5-year funding sets us in motion to bring faculty together across our university and with neighbors across our state to move forward counteracting the burden of cancer due to obesity. We have previously written on just how great this is for our nation.(see Obesity and Cancer. Wolin, et al. 2010.) Now we are linked to colleagues in other centers to learn from our collective efforts. 



The quick summary of our center is available through this link. "Transdisciplinary Center Approach to Examine Multilevel and Multigenerational Associations Between Obesity and Cancer". 


Over the coming months we will add updates on progress as we expand our research and translation to practice to address obesity and prevent cancer.

(Video) Eight Ways to Prevent Cancer - Exercise

Next up in the Eight Ways to Prevent Cancer video series: Exercise.

CNiC's Dr. Kate Wolin walks us through the huge benefits we get from exercise, including a lower risk of heart disease and diabetes, on top of the cancer benefits many people may not be aware of. The video also highlights the fantastic progress of a cancer survivor who went from walking just over a 1,000 steps per week, to over 6,000 steps per day - on her way to an ultimate goal of 10,000 per day.

Wolin's quote sums it up best:  "It's never too early to start being active, but it's certainly never too late."

Timing is everything: Renewing the debate on aspirin

This week on the NY Times Well Blog is a discussion of whether the health benefits of aspirin have been oversold (or the health risks underreported). The spark to this renewed discussion is a Cochrane review of the aspirin data. What gets lost in the debate, is how important timing is when considering the health benefits of aspirin use. As we've previously noted here on CNiC, the benefits of aspirin use for colorectal cancer risk reduction and reduction in colorectal cancer mortality really become apparent after a decade or more of use. With a mean follow-up of 6 years, the latest review by Seshasai et al, wouldn't capture the full benefit of regular aspirin use.